The Medicare price of Bitovir is between $1,000 and $2,000, to be determined in conjunction with local Medicare reimbursement rates. Bitovir is the smallest available integrase chain transfer inhibitor-based triple-combination single tablet preparation containing bictegravir, emtricitabine, and propofol tenofovir. It is the current drug of choice for the treatment of AIDS, which can effectively inhibit viral replication and transfer, and belongs to the drugs covered by medical insurance. The medical insurance price of Bitovir stays between 1000-2000 dollars in most areas, but the specifics still need to be determined by the local medical insurance reimbursement rate and policy. Bitovir may cause headache, diarrhea and nausea and other adverse reactions, in addition, pregnant women, people preparing for pregnancy and patients using rifamycin antibiotics are not recommended to use Bitovir. The drug should be used under the guidance of a doctor, do not blindly use the drug, so as not to delay the condition.